Back to Search Start Over

Neuronal intranuclear inclusion disease is genetically heterogeneous.

Authors :
Chen Z
Yan Yau W
Jaunmuktane Z
Tucci A
Sivakumar P
Gagliano Taliun SA
Turner C
Efthymiou S
Ibáñez K
Sullivan R
Bibi F
Athanasiou-Fragkouli A
Bourinaris T
Zhang D
Revesz T
Lashley T
DeTure M
Dickson DW
Josephs KA
Gelpi E
Kovacs GG
Halliday G
Rowe DB
Blair I
Tienari PJ
Suomalainen A
Fox NC
Wood NW
Lees AJ
Haltia MJ
Hardy J
Ryten M
Vandrovcova J
Houlden H
Source :
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Sep; Vol. 7 (9), pp. 1716-1725. Date of Electronic Publication: 2020 Aug 10.
Publication Year :
2020

Abstract

Neuronal intranuclear inclusion disease (NIID) is a clinically heterogeneous neurodegenerative condition characterized by pathological intranuclear eosinophilic inclusions. A CGG repeat expansion in NOTCH2NLC was recently identified to be associated with NIID in patients of Japanese descent. We screened pathologically confirmed European NIID, cases of neurodegenerative disease with intranuclear inclusions and applied in silico-based screening using whole-genome sequencing data from 20 536 participants in the 100 000 Genomes Project. We identified a single European case harbouring the pathogenic repeat expansion with a distinct haplotype structure. Thus, we propose new diagnostic criteria as European NIID represents a distinct disease entity from East Asian cases.<br /> (© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.)

Details

Language :
English
ISSN :
2328-9503
Volume :
7
Issue :
9
Database :
MEDLINE
Journal :
Annals of clinical and translational neurology
Publication Type :
Academic Journal
Accession number :
32777174
Full Text :
https://doi.org/10.1002/acn3.51151